2025-09-11T10:58:20-05:00 2025-04-30 871353108 EISNER ADVISORY GROUP LLC 130 NORTH 18TH STREET SUITE 3000 PHILADELPHIA PA 191032757 990 2024-05-01 061619523 ALLIANCE FOR CANCER GENE THERAPY INC ALLI 2033585055 96 CUMMINGS POINT ROAD STAMFORD CT 06902 KEVIN HONEYCUTT CEO AND PRESIDENT 2033585055 2025-09-10 1 0 HELEN M MARTIN P01330899 2158818800 2024 2025-03-06 01:10:19Z KEVIN HONEYCUTT 96 CUMMINGS POINT ROAD STAMFORD CT 06902 6534765 0 X WWW.ACGTFOUNDATION.ORG X 2001 CT ALLIANCE FOR CANCER GENE THERAPY (ACGT) FUNDS THE MOST INNOVATIVE SCIENTISTS (CONTINUED IN SCH O) WORKING TO HARNESS THE POWER OF CELL AND GENE THERAPY TO TRANSFORM HOW CANCER IS TREATED AND DRIVE MOMENTUM TOWARD A CURE. 15 15 3 33 0 0 1541034 1933872 19587 98042 294442 917192 7204115 154414 9059178 3103520 1025424 4328750 0 0 596287 581564 0 0 356823 344491 445232 1966202 5355546 7092976 -2252026 15042870 15733028 919115 3506891 14123755 12226137 X ACGT SUPPORTS HIGH-RISK, HIGH-REWARD SCIENTIFIC RESEARCH TO DEVELOP CANCER THERAPEUTICS THAT USE THE BODY'S OWN CELLS AND GENES AS A LIVING MEDICINE. BY ACCELERATING THIS RESEARCH, ACGT IS HELPING TO ADVANCE THERAPIES THAT ARE SIGNIFICANTLY MORE EFFECTIVE AND LESS TOXIC THAN CURRENT CANCER TREATMENTS SUCH AS CHEMOTHERAPY AND RADIATION. 0 0 4933585 4328750 284595 IN FISCAL 4/30/25, ACGT FUNDED CLINICAL INVESTIGATOR GRANTS AWARDED TO INNOVATIVE SCIENTISTS CONDUCTING TRANSLATIONAL RESEARCH AT PREMIER ACADEMIC INSTITUTIONS IN THE U.S., EACH FOCUSING ON THE DEVELOPMENT OF CANCER CELL AND GENE THERAPIES FOR DIFFERENT CANCERS, INCLUDING PANCREATIC, PEDIATRIC, AND BRAIN CANCERS, AND CANCER METASTASIS. ACGT CONTINUED MULTI-YEAR COLLABORATIONS WITH MULTI-DISCIPLINARY 501(C)(3) ORGANIZATIONS FOCUSED ON CELL AND GENE THERAPY RESEARCH. ACGT FURTHER CONVENED ITS ANNUAL SCIENTIFIC SUMMIT AND ALSO INCREASED PUBLIC AWARENESS OF CELL AND GENE THERAPY RESEARCH THROUGH ACGT'S WEBSITE, SOCIAL MEDIA, AND IMPACT REPORTS. 4933585 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 X 4 0 1 3 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 15 15 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AK AR CA CO CT FL GA HI IL KS KY MD MA MI MN MS NE NH NJ NM NY NC ND OH OR PA RI SC TN UT VA WA WV WI X X COLLEEN P MAGGI TREASURER 2033588000 96 CUMMINGS POINT ROAD STAMFORD CT 06902 KEVIN HONEYCUTT CEO & PRESIDENT 40.00 X X 0 0 0 MARC ENGELSGJERD MD DIRECTOR (EFF 12/5/24) 1.00 X 0 0 0 DANIEL ENGLANDER DIRECTOR 1.00 X 0 0 0 MARIA FARDIS PHD DIRECTOR 1.00 X 0 0 0 PETER A GLICKLICH ESQ DIRECTOR 1.00 X 0 0 0 MICHAEL GREGORY DIRECTOR 1.00 X 0 0 0 CHAU Q KHUONG DIRECTOR 1.00 X 0 0 0 JOHN LAHEY PHD DIRECTOR 1.00 X 0 0 0 ALEXANDRA LANDES DIRECTOR 1.00 X 0 0 0 BRUCE L LEVINE PHD DIRECTOR 1.00 X 0 0 0 BARBARA NETTER DIRECTOR, HONORARY CHAIRMAN 6.00 X 0 0 0 CHEN SCHOR DIRECTOR 1.00 X 0 0 0 JOHN C SITES JR DIRECTOR 1.00 X 0 0 0 KLAUS R VEITINGER MD PHD DIRECTOR 1.00 X 0 0 0 MARTIN E WINTER DIRECTOR 1.00 X 0 0 0 GBOLA AMUSA DIRECTOR (THRU 6/27/24) 1.00 X 0 0 0 THERESA BURGESS PHD DIRECTOR (THRU 6/27/24) 1.00 X 0 0 0 H WILLIAM SMITH VICE PRESIDENT, LEGAL & SECRETARY 2.00 X 0 0 0 CHRISTINE HERMAN VICE PRESIDENT, TREAS(THRU 5/31/25) 2.00 X 0 0 0 BARBARA LAVERY CHIEF PROGRAM OFFICER 40.00 X 264230 0 8992 KERI EISENBERG CHIEF PHILANTHROPY OFFICER 40.00 X 215301 0 8081 479531 0 17073 2 0 1 0 0 148933 1784939 1933872 ACGT SUMMIT 2025 541900 98042 98042 98042 398775 398775 186553 186553 3889523 3371106 518417 518417 518417 28000 148933 60139 -32139 -32139 3103520 284595 0 885053 4328750 4328750 538643 296159 242484 11827 6505 5322 994 641 353 30100 16555 13545 6862 5147 1715 49319 7945 25273 16101 48003 42108 5895 24958 12479 12479 87435 47245 14280 25910 43195 27397 15798 142523 131184 6324 5015 MISCELLANEOUS 42937 11470 17546 13921 5355546 4933585 65138 356823 818744 454545 910223 2819391 31119 162208 67206 30653 98517 13184925 1439647 10758720 15042870 15733028 31650 32587 887465 3474304 919115 3506891 X 12042970 12226137 2080785 0 14123755 12226137 15042870 15733028 -2252026 354408 0 X 0 1 X 1 0 X 1415167 2454379 2202186 1541034 1933872 9546638 1415167 2454379 2202186 1541034 1933872 9546638 4788023 4758615 93859 73459 134870 447003 585328 1334519 10881157 7117629 0.43730 0.51570 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 VANGUARD FTSE EMERGING MARKETS EFT 2957404 F ENERGY SELECT SECTOR SPDR EFT 886305 F ISHARES CORE S&P 500 EFT 2150936 F SPDR GOLD TRUST GOLD SHARES 1751538 F US TREASURY NOTE 4.875% DUE 11/30/25 3012537 F 10758720 X 4132970 354408 767395 1121803 3011167 92353 92353 3103520 6030588 767395 767395 5263193 92353 92353 5355546 PART X, LINE 2: ACGT IS INCORPORATED IN THE STATE OF CONNECTICUT. IN 2001, ACGT RECEIVED AN EXEMPTION FROM FEDERAL INCOME TAXES FROM THE INTERNAL REVENUE SERVICE UNDER SECTION 501(A) OF THE INTERNAL REVENUE CODE AS AN ORGANIZATION DESCRIBED IN SECTION 501(C)(3). U.S. GAAP REQUIRES MANAGEMENT TO EVALUATE TAX POSITIONS TAKEN, AND RECOGNIZE A TAX LIABILITY, IF ACGT HAS TAKEN AN UNCERTAIN TAX POSITION THAT MORE LIKELY THAN NOT WOULD NOT BE SUSTAINED UPON EXAMINATION BY A GOVERNMENT AUTHORITY. MANAGEMENT HAS ANALYZED THE TAX POSITIONS TAKEN BY ACGT AND HAS CONCLUDED THAT, AS OF APRIL 30, 2025 AND 2024, THERE ARE NO UNCERTAIN POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD REQUIRE RECOGNITION OF A LIABILITY OR DISCLOSURE IN THE FINANCIAL STATEMENTS. ACGT RECOGNIZES ACCRUED INTEREST AND PENALTIES ASSOCIATED WITH UNCERTAIN TAX POSITIONS, IF ANY. THERE WERE NO INCOME TAX RELATED INTEREST AND PENALTIES RECORDED FOR THE YEARS ENDED APRIL 30, 2025 AND 2024. PART XI, LINE 4B - OTHER ADJUSTMENTS: ACGT SUMMIT 2025 EXPENSES 92,353. PART XII, LINE 4B - OTHER ADJUSTMENTS: ACGT SUMMIT 2025 EXPENSES 92,353. GALA LUNCHEON 176933 148933 28000 3000 21000 36139 176933 148933 28000 3000 21000 36139 60139 -32139 1 THE CHILDREN'S HOSPITAL OF PHILADELPHIA 2716 SOUTH STREET PHILADELPHIA PA 191462305 231352166 501(C)(3) 1462868 0 CANCER RESEARCH UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD HOUSTON TX 770304009 746001118 501(C)(3) 6483 0 CANCER RESEARCH ST JUDE CHILDREN'S RESEARCH HOSPITAL 262 DANNY THOMAS PLACE MEMPHIS TN 38105 351044585 501(C)(3) 1446554 0 CANCER RESEARCH FRED HUTCHINSON CANCER CENTER 1100 FAIRVIEW AVE D3-100 SEATTLE WA 981091024 911935159 501(C)(3) 482561 0 CANCER RESEARCH UNIVERSITY OF PENNSYLVANIA OFFICE OF RESEARCH SERVICES 3451 WALNUT ST 5TH FLOOR FRANKLIN BUILDING PHILADELPHIA PA 191046205 231352685 501(C)(3) 930284 0 CANCER RESEARCH 5 0 PART I, LINE 2: THE SCIENTIFIC ADVISORY COUNCIL REVIEWS APPLICATIONS AND PRESENTS SAME TO THE BOARD OF DIRECTORS, WHEREUPON ACGT'S GRANTS ARE MADE PURSUANT TO GRANT AGREEMENTS, WHICH REQUIRE PERIODIC REPORTING OF RESULTS BY GRANTEE ORGANIZATIONS. 0 0 0 0 0 0 0 0 0 BARBARA LAVERY CHIEF PROGRAM OFFICER 226908 0 35000 0 2322 0 6703 0 2289 0 273222 0 0 0 KERI EISENBERG CHIEF PHILANTHROPY OFFICER 199059 0 15000 0 1242 0 6459 0 1622 0 223382 0 0 0 FORM 990, PART V, LINE 2B: ACGT PARTNERS WITH TRINET AND TRINET PROVIDES PAYROLL SERVICES FOR ACGT. BECAUSE TRINET IS THE PAYROLL PROVIDER/OWNER (NOT ACGT), ACGT DOES NOT HAVE A W-3 AND TRINET WILL NOT PROVIDE ACGT WITH A COPY OF THE W-3S OR THE W-2S. ACGT DOES HAVE ACCESS TO THE INFORMATION VIA OTHER VARIOUS REPORTS BUT HAS OBTAINED COPIES OF THE 2024 W-2S FOR THE OFFICER AND KEY EMPLOYEE (AS DEFINED BELOW) FROM THOSE INDIVIDUALS. FORM 990, PART VI, SECTION A, LINE 2 H. WILLIAM SMITH AND CHRISTINE HERMAN ARE OFFICERS OF AN ENTITY CONTROLLED BY BARBARA NETTER, ACGT'S HONORARY CHAIRMAN. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY THE ENTIRE BOARD PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C BOARD OF DIRECTORS AND OFFICERS ANNUALLY REVIEW THE COMPLETED CONFLICT OF INTEREST QUESTIONNAIRES. FORM 990, PART VI, SECTION C, LINE 19 DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC VIA THE WEBSITE AND UPON REQUEST.